Investing.com - Zai Lab (NASDAQ:ZLAB) reported on Monday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Zai Lab announced earnings per share of $-3.46 on revenue of $49M. Analysts polled by Investing.com anticipated EPS of $-0.3982 on revenue of $5M.
Zai Lab shares are up 9% from the beginning of the year, still down 23.78% from its 52 week high of $193.54 set on January 20. They are outperforming the Nasdaq which is up 2.36% from the start of the year.
Zai Lab shares gained 0.33% in pre-market trade following the report.
Zai Lab follows other major Healthcare sector earnings this month
Zai Lab's report follows an earnings missed by Roche Holding ADR on February 1, who reported EPS of $1.21 on revenue of $15.88B, compared to forecasts EPS of $1.28 on revenue of $16.45B.
AbbVie had beat expectations on February 3 with fourth quarter EPS of $2.92 on revenue of $13.86B, compared to forecast for EPS of $2.85 on revenue of $13.7B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar